Time for Peer Review Reform

In response to Eugene Russo's article on bypassing peer review,1 we wish to share a recent peer review experience with your readers. We submitted a manuscript to the university-based editor of a well-respected journal and after two weeks received a faxed acknowledgment of receipt. After two months we inquired about the manuscript and were told that by mistake it had been sent for review to the wrong journal and was being resubmitted for review by the correct journal. After an additional two mont

Written byRaphael Stricker
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In response to Eugene Russo's article on bypassing peer review,1 we wish to share a recent peer review experience with your readers. We submitted a manuscript to the university-based editor of a well-respected journal and after two weeks received a faxed acknowledgment of receipt. After two months we inquired about the manuscript and were told that by mistake it had been sent for review to the wrong journal and was being resubmitted for review by the correct journal. After an additional two months, we inquired about the manuscript and were told that it was "on the editor's desk." Two months later, after several more inquiries, we received a one-paragraph editor's note rejecting the manuscript with the sole comment that it would be "better suited for another journal." After six months, there was not even a peer reviewer's comment to show for our work.

If we had submitted our manuscript to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies